After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
TECH belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Bio-Techne Corp is $9.13B. A total of 1.65 million shares were traded on the day, compared to an average of 2.28M shares.
In the most recent transaction, Nusse Roeland sold 17,040 shares of TECH for 56.36 per share on Aug 25 ’25. After the transaction, the Director now owns 44,559 company shares. In a previous transaction on Aug 25 ’25, BAUMGARTNER ROBERT V sold 17,040 shares at 56.21 per share. TECH shares that Director owns now total 44,863.
Among the insiders who bought shares, ROELAND NUSSE acquired of 17,040 shares on Aug 25 ’25 at a per-share price of $56.36. In another insider transaction, ROBERT V. BAUMGARTNER4731 BONI bought 17,040 shares at $56.21 per share on Aug 25 ’25.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Bio-Techne Corp pays an annual dividend of $0.32, resulting in a dividend yield of 0.55%, and it has a price to earnings (P/E) ratio of 119.81.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, TECH has a high of $79.28 and a low of $46.01.
As of this writing, TECH has an earnings estimate of $0.43 per share for the current quarter. EPS was calculated based on a consensus of 12.0 estimates, with a high estimate of $0.46 per share and a lower estimate of $0.41. The company reported an EPS of $0.42 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. TECH’s latest balance sheet shows that the firm has $247.03M in Cash & Short Term Investments as of fiscal 2022. There were $325.97M in debt and $176.02M in liabilities at the time. Its Book Value Per Share was $12.62, while its Total Shareholder’s Equity was $1.70B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TECH is Buy with a score of 4.47.
